Charlotte Ann Rhee, | |
33 Walt Whitman Rd, Suite 228, Huntington Station, NY 11746-3640 | |
(631) 424-6707 | |
Not Available |
Full Name | Charlotte Ann Rhee |
---|---|
Gender | Female |
Speciality | Plastic Surgery |
Location | 33 Walt Whitman Rd, Huntington Station, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932287968 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 199336-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Charlotte Ann Rhee, 33 Walt Whitman Rd, Suite 228, Huntington Station, NY 11746-3640 Ph: (631) 424-6707 | Charlotte Ann Rhee, 33 Walt Whitman Rd, Suite 228, Huntington Station, NY 11746-3640 Ph: (631) 424-6707 |
News Archive
Using a combination of genetic linkage, microarray gene expression and genetic association studies, a group of Brigham and Women's Hospital/ Harvard Medical School researchers have identified a serine protease inhibitor clade E, member 2, or SERPINE2, "as a novel candidate susceptibility gene for COPD," according to Sorachai Srisuma
You may not be fully dressed without a smile, but a look of horror will make a faster first impression.
Incyte Corporation announces updated data from its ongoing Phase 2 FIGHT-202 trial evaluating pemigatinib (INCB54828), its selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced/metastatic or surgically unresectable cholangiocarcinoma (bile duct cancer) who failed at least one previous treatment.
Today, the U.S. Food and Drug Administration announced participation in several new collaborative communities aimed at addressing challenges in patient health care.
› Verified 7 days ago